BIOMIMETIX JV LLC
Englewood, CO · Biotech · Private
BMX-001, a metalloporphyrin pharmaceutical that scavenges reactive oxygen species to protect against radiation-induced brain damage while enhancing tumor growth inhibition
- Grants
- $15M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 3 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $976,447 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $1,023,555 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | $247,352 | |
| Federal grant | Department of Health and Human Services · Phase I · Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | $475,175 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | $1,000,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $4,001,625 | |
| Federal grant | Department of Health and Human Services · Phase I · Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | $227,823 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | $600,000 | |
| Federal grant | Department of Health and Human Services · Phase II · BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | $1,625 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1658 | PHAGE REFINERY, INC. | — | — |
| 1659 | JUVENA THERAPEUTICS INC | — | — |
| 1660 | ISOTHERAPEUTICS GROUP, LLC | — | — |
| 1661 | BIOMIMETIX JV LLC | — | — |
| 1662 | OGB5, INC. | — | — |
| 1663 | CHEMEDIMMUNE, INC. | — | — |
| 1664 | KXT BIO INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Hydrophobic Compositions Including A Hydrophilic Active Ingredient And Methods Relating Theretoapplication
- Methods Of Treating Pruritusgranted
- Methods Of Making Substituted Porphyrin Pharmaceutical Compounds And Compositionsapplication
- Methods Of Treating Pruritusgranted
- Methods Of Treating Skin Disordersgranted
- Methods Of Treating Pruritusapplication
- Methods For Reducing Ischemia-reperfusion Injuriesapplication
- Methods Of Treating Skin Disordersapplication
- Hydrophobic Compositions Including A Hydrophilic Active Ingredient And Methods Relating Theretoapplication
- Methods, Compositions, And Kits For Treating Inflammatory Skin Conditionsapplication
- Methods Of Making Substituted Porphyrin Pharmaceutical Compounds And Compositionsapplication
- Methods, Compositions, And Kits For Treating And/or Preventing A Side Effect Associated With Radiation And/or Chemotherapy Exposureapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.